3.7.0.1 html 133 281 1 false 45 0 false 7 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) Statements 4 false false R5.htm 100050 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 100060 - Disclosure - Nature of the Business Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureNatureOfBusiness Nature of the Business Notes 6 false false R7.htm 100070 - Disclosure - Basis of Presentation and Consolidation Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBasisOfPresentationAndConsolidation Basis of Presentation and Consolidation Notes 7 false false R8.htm 100080 - Disclosure - Sale of Commercial Business Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSaleOfCommercialBusiness Sale of Commercial Business Notes 8 false false R9.htm 100090 - Disclosure - Going Concern Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureGoingConcern Going Concern Notes 9 false false R10.htm 100100 - Disclosure - Income Taxes Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 10 false false R11.htm 100110 - Disclosure - Net Income (Loss) Per Common Share Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureNetIncomeLossPerCommonShare Net Income (Loss) Per Common Share Notes 11 false false R12.htm 100120 - Disclosure - Fair Value of Financial Instruments Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstruments Fair Value of Financial Instruments Notes 12 false false R13.htm 100130 - Disclosure - Marketable Securities Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureMarketableSecurities Marketable Securities Notes 13 false false R14.htm 100140 - Disclosure - Accounts Payable, Accrued Expenses and Other Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOther Accounts Payable, Accrued Expenses and Other Notes 14 false false R15.htm 100150 - Disclosure - Borrowings Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBorrowings Borrowings Notes 15 false false R16.htm 100160 - Disclosure - Stock-Based Compensation Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 100170 - Disclosure - Recent Accounting Pronouncements Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureRecentAccountingPronouncements Recent Accounting Pronouncements Notes 17 false false R18.htm 100180 - Disclosure - Subsequent Events Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 18 false false R19.htm 100190 - Disclosure - Recent Accounting Pronouncements (Policies) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureRecentAccountingPronouncementsPolicies Recent Accounting Pronouncements (Policies) Policies http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureRecentAccountingPronouncements 19 false false R20.htm 100200 - Disclosure - Basis of Presentation and Consolidation (Tables) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBasisOfPresentationAndConsolidationTables Basis of Presentation and Consolidation (Tables) Tables http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBasisOfPresentationAndConsolidation 20 false false R21.htm 100210 - Disclosure - Sale of Commercial Business (Tables) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSaleOfCommercialBusinessTables Sale of Commercial Business (Tables) Tables http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSaleOfCommercialBusiness 21 false false R22.htm 100220 - Disclosure - Net Income (Loss) Per Common Share (Tables) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureNetIncomeLossPerCommonShareTables Net Income (Loss) Per Common Share (Tables) Tables http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureNetIncomeLossPerCommonShare 22 false false R23.htm 100230 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) Tables http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstruments 23 false false R24.htm 100240 - Disclosure - Accounts Payable, Accrued Expenses and Other (Tables) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOtherTables Accounts Payable, Accrued Expenses and Other (Tables) Tables http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOther 24 false false R25.htm 100250 - Disclosure - Borrowings (Tables) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBorrowingsTables Borrowings (Tables) Tables http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBorrowings 25 false false R26.htm 100260 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureStockBasedCompensation 26 false false R27.htm 100270 - Disclosure - Nature of the Business - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureNatureOfBusinessAdditionalInformationDetail Nature of the Business - Additional Information (Detail) Details 27 false false R28.htm 100280 - Disclosure - Basis of Presentation and Consolidation - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBasisOfPresentationAndConsolidationAdditionalInformationDetail Basis of Presentation and Consolidation - Additional Information (Detail) Details 28 false false R29.htm 100290 - Disclosure - Basis of Presentation and Consolidation - Schedule of Non-Controlling Interest in Subsidiary (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBasisOfPresentationAndConsolidationScheduleOfNonControllingInterestInSubsidiaryDetail Basis of Presentation and Consolidation - Schedule of Non-Controlling Interest in Subsidiary (Detail) Details 29 false false R30.htm 100300 - Disclosure - Sale of Commercial Business - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSaleOfCommercialBusinessAdditionalInformationDetail Sale of Commercial Business - Additional Information (Detail) Details 30 false false R31.htm 100310 - Disclosure - Sale of Commercial Business - Schedule of Discontinued Operations and Assets Held for Sale (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSaleOfCommercialBusinessScheduleOfDiscontinuedOperationsAndAssetsHeldForSaleDetail Sale of Commercial Business - Schedule of Discontinued Operations and Assets Held for Sale (Detail) Details 31 false false R32.htm 100320 - Disclosure - Sale of Commercial Business - Schedule of Carrying Value of Assets and Liabilities Classified as Assets Held for Sale Relates to Commercial Business (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSaleOfCommercialBusinessScheduleOfCarryingValueOfAssetsAndLiabilitiesClassifiedAsAssetsHeldForSaleRelatesToCommercialBusinessDetail Sale of Commercial Business - Schedule of Carrying Value of Assets and Liabilities Classified as Assets Held for Sale Relates to Commercial Business (Detail) Details 32 false false R33.htm 100330 - Disclosure - Sale of Commercial Business - Schedule of Inventory of Commercial Business (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSaleOfCommercialBusinessScheduleOfInventoryOfCommercialBusinessDetail Sale of Commercial Business - Schedule of Inventory of Commercial Business (Detail) Details 33 false false R34.htm 100340 - Disclosure - Sale of Commercial Business - Summary of Charges Related to Restructuring Activities (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSaleOfCommercialBusinessSummaryOfChargesRelatedToRestructuringActivitiesDetail Sale of Commercial Business - Summary of Charges Related to Restructuring Activities (Detail) Details 34 false false R35.htm 100350 - Disclosure - Going Concern - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureGoingConcernAdditionalInformationDetail Going Concern - Additional Information (Detail) Details 35 false false R36.htm 100360 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 36 false false R37.htm 100370 - Disclosure - Net Income (Loss) Per Common Share - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureNetIncomeLossPerCommonShareAdditionalInformationDetail Net Income (Loss) Per Common Share - Additional Information (Detail) Details http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureNetIncomeLossPerCommonShareTables 37 false false R38.htm 100380 - Disclosure - Net Income (Loss) Per Common Share - Schedule of Outstanding Securities Excluded from Computation of Diluted Loss Per Share (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureNetIncomeLossPerCommonShareScheduleOfOutstandingSecuritiesExcludedFromComputationOfDilutedLossPerShareDetail Net Income (Loss) Per Common Share - Schedule of Outstanding Securities Excluded from Computation of Diluted Loss Per Share (Detail) Details http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureNetIncomeLossPerCommonShareTables 38 false false R39.htm 100390 - Disclosure - Fair Value of Financial Instruments - Schedule of Assets Measured at Fair Value on a Recurring Basis (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfAssetsMeasuredAtFairValueOnRecurringBasisDetail Fair Value of Financial Instruments - Schedule of Assets Measured at Fair Value on a Recurring Basis (Detail) Details 39 false false R40.htm 100400 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformationDetail Fair Value of Financial Instruments - Additional Information (Detail) Details 40 false false R41.htm 100410 - Disclosure - Marketable Securities - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetail Marketable Securities - Additional Information (Detail) Details 41 false false R42.htm 100420 - Disclosure - Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOtherScheduleOfAccountsPayableAccruedExpensesAndOtherDetail Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Details 42 false false R43.htm 100430 - Disclosure - Borrowings - 2022 Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBorrowings2022NotesAdditionalInformationDetail Borrowings - 2022 Notes - Additional Information (Detail) Details 43 false false R44.htm 100440 - Disclosure - Borrowings - Convertible Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBorrowingsConvertibleNotesAdditionalInformationDetail Borrowings - Convertible Notes - Additional Information (Detail) Details 44 false false R45.htm 100450 - Disclosure - Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureBorrowingsScheduleOfFutureMinimumPaymentsUnderLoansPayableDetail Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Details 45 false false R46.htm 100460 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 46 false false R47.htm 100470 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToCalculateFairValueOfOptionsGrantedToEmployeesDetail Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees (Detail) Details 47 false false R48.htm 100480 - Disclosure - Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRecognizedStockBasedCompensationExpenseDetail Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Details 48 false false R49.htm 100490 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetail Stock-Based Compensation - Summary of Stock Option Activity (Detail) Details 49 false false R50.htm 100500 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.merrimackpharma.com/20170630/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetail Subsequent Events - Additional Information (Detail) Details 50 false false All Reports Book All Reports mack-20170630.xml mack-20170630.xsd mack-20170630_cal.xml mack-20170630_def.xml mack-20170630_lab.xml mack-20170630_pre.xml true true